Dispersa Labs creates and enables new products based on its proprietary dry powder technology. In late 2019 we launched Sula breathable cannabis into California's regulated medical cannabis market. Sula is the world's first dry powder inhaler (DPI) for cannabinoids.
Company Details
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- breathesula.com
- Keywords
- Mumbai.
Dispersa Labs, Inc Questions
Dispersa Labs, Inc's website is breathesula.com
Dispersa Labs, Inc's LinkedIn profile is https://www.linkedin.com/company/dispersa-labs-inc
Dispersa Labs, Inc's industry is
Biotechnology Research
Dispersa Labs, Inc's top competitors are
Q² Solutions,
Nexelis, A Q² Solutions Company,
Spektus Pharma,
Neopharm Labs,
Dispersa,
Solstar Pharma,
Universal Interlink | Branding & Social Media Agency,
Altus Drug Development,
Dispersa Juguetes S.l..
Dispersa Labs, Inc's categories are Biotechnology Research
